Notice: Use of undefined constant CHILD_THEME_VERSION - assumed 'CHILD_THEME_VERSION' in E:\bsef.com\wp-content\themes\bridge-child\functions.php on line 34
Rome: On 30 October 2014, the 10th meeting of the Persistent Organic Pollutant Review Committee (POPRC) of the UNEP Stockholm Convention adopted a risk profile for commercial Deca-BDE // MISSING LINK. POPRC decided that Deca-BDE’s main constituent BDE-209 “is likely as a result of its long range environmental transport to lead to significant adverse human health and environmental effects such that global action is warranted”. POPRC members have therefore decided to start an evaluation of risk control measures, alternatives, waste implications and socio-economic impacts through the development of a risk management evaluation (RME)  for commercial Deca-BDE. Stakeholders are asked to submit information to be considered by 5 January 2015.
A draft RME will be developed by Norway for discussion by POPRC in October 2015. This is the next step in a listing process that takes several years. A POP listing can only be confirmed by the Conference of the Parties. At the earliest a potential listing of BDE-209 could be decided at the meeting scheduled for May 2017 and implemented by the end of 2018.
In BSEF’s opinion, there is no clear evidence for bioaccumulation of BDE-209 and it does not meet the criteria for adverse effects as result of its long range transport. Furthermore the adopted risk profile does not represent a balanced overview of the scientific data, and would have greatly benefited from more time for members to properly review the weight of evidence of the extensive, sometimes contradictory and often new references. BSEF regrets that a decision to adopt the risk profile has been taken without appropriate review of some of the underlying evidence put forward.
BSEF believes that this risk profile raises some important questions about how scientific data is interpreted when reviewing if a chemical meets the POP criteria. Given the global impact and importance of the Stockholm Convention it is vital that Risk Profiles are of high quality and based on a well-balanced evaluation of the information.
One of the major consequences of a potential POP listing will be impacts for the management of products containing commercial Deca-BDE once they become waste. BSEF therefore encourages downstream users to engage in the RME process to ensure an accurate picture of the current uses and applications.
BSEF will continue to actively engage in this process.
 The decision has not yet been published but will be available here along with the POPRC10 meeting report and all decisions adopted at the meeting:http://chm.pops.int/TheConvention/POPsReviewCommittee/ReportsandDecisions/tabid/3309/Default.aspx
 A Risk Management Evaluation is developed on the basis of information submitted related to the criteria set out in Annex F of the Stockholm Convention.